Cargando…

Improving the Acceptance Rate of Centchroman As a Postpartum Contraceptive Through a Quality Improvement Initiative

Background The unmet need for contraception is two-pronged: a spacing method and a permanent method. Centchroman, a non-hormonal, non-steroidal oral contraceptive, is suitable for both of these purposes. The Government of India provides it free of cost under the name "Chhaya", but its curr...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarkar, Avir, Wadhawan, Isha, Raj, Anjaly, Nagabhushana, Prerana, Singh, Preeti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580608/
https://www.ncbi.nlm.nih.gov/pubmed/36277560
http://dx.doi.org/10.7759/cureus.29277
_version_ 1784812425950789632
author Sarkar, Avir
Wadhawan, Isha
Raj, Anjaly
Nagabhushana, Prerana
Singh, Preeti
author_facet Sarkar, Avir
Wadhawan, Isha
Raj, Anjaly
Nagabhushana, Prerana
Singh, Preeti
author_sort Sarkar, Avir
collection PubMed
description Background The unmet need for contraception is two-pronged: a spacing method and a permanent method. Centchroman, a non-hormonal, non-steroidal oral contraceptive, is suitable for both of these purposes. The Government of India provides it free of cost under the name "Chhaya", but its current acceptance rates are lower than expected. We aimed to increase the acceptance rates of centchroman as a postpartum contraceptive through a quality improvement (QI) approach conducted over eight months at a tertiary care hospital in North India. Materials and Methods This QI study was done in three phases: a pre-intervention phase of over eight weeks to assess the baseline acceptance and prevalence rates of centchroman use; an intervention phase of over 12 weeks involving three Plan-Do-Study-Act (PDSA) cycles to increase the awareness and acceptance of centchroman among the target population using visual aids and counselling by the nursing staff and resident doctors, respectively; and a post-intervention phase of over 12 weeks to assess the acceptance and continuation rates of Chhaya. Results The acceptance rates for centchroman increased from a baseline of 2.9% to 15.3%, 56.3%, and 78.2% after the first, second, and third PDSA cycles, respectively. On follow-up, continuation rates were 96.7%, 89.5%, and 78.6% at one, three, and six months, respectively. The majority of women reported only minor side effects, with the primary reason for discontinuation being a preference for intrauterine devices or medroxyprogesterone acetate injections over Chhaya.  Conclusion The postpartum period provides an important window of opportunity to counsel women for contraception. Despite an enviable safety profile and dosing schedule, centchroman remains largely under-utilized. Increasing awareness among women as well as health care workers may improve the acceptance of centchroman and help reduce the burden of untimely and unwanted conceptions.
format Online
Article
Text
id pubmed-9580608
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-95806082022-10-21 Improving the Acceptance Rate of Centchroman As a Postpartum Contraceptive Through a Quality Improvement Initiative Sarkar, Avir Wadhawan, Isha Raj, Anjaly Nagabhushana, Prerana Singh, Preeti Cureus Obstetrics/Gynecology Background The unmet need for contraception is two-pronged: a spacing method and a permanent method. Centchroman, a non-hormonal, non-steroidal oral contraceptive, is suitable for both of these purposes. The Government of India provides it free of cost under the name "Chhaya", but its current acceptance rates are lower than expected. We aimed to increase the acceptance rates of centchroman as a postpartum contraceptive through a quality improvement (QI) approach conducted over eight months at a tertiary care hospital in North India. Materials and Methods This QI study was done in three phases: a pre-intervention phase of over eight weeks to assess the baseline acceptance and prevalence rates of centchroman use; an intervention phase of over 12 weeks involving three Plan-Do-Study-Act (PDSA) cycles to increase the awareness and acceptance of centchroman among the target population using visual aids and counselling by the nursing staff and resident doctors, respectively; and a post-intervention phase of over 12 weeks to assess the acceptance and continuation rates of Chhaya. Results The acceptance rates for centchroman increased from a baseline of 2.9% to 15.3%, 56.3%, and 78.2% after the first, second, and third PDSA cycles, respectively. On follow-up, continuation rates were 96.7%, 89.5%, and 78.6% at one, three, and six months, respectively. The majority of women reported only minor side effects, with the primary reason for discontinuation being a preference for intrauterine devices or medroxyprogesterone acetate injections over Chhaya.  Conclusion The postpartum period provides an important window of opportunity to counsel women for contraception. Despite an enviable safety profile and dosing schedule, centchroman remains largely under-utilized. Increasing awareness among women as well as health care workers may improve the acceptance of centchroman and help reduce the burden of untimely and unwanted conceptions. Cureus 2022-09-17 /pmc/articles/PMC9580608/ /pubmed/36277560 http://dx.doi.org/10.7759/cureus.29277 Text en Copyright © 2022, Sarkar et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Obstetrics/Gynecology
Sarkar, Avir
Wadhawan, Isha
Raj, Anjaly
Nagabhushana, Prerana
Singh, Preeti
Improving the Acceptance Rate of Centchroman As a Postpartum Contraceptive Through a Quality Improvement Initiative
title Improving the Acceptance Rate of Centchroman As a Postpartum Contraceptive Through a Quality Improvement Initiative
title_full Improving the Acceptance Rate of Centchroman As a Postpartum Contraceptive Through a Quality Improvement Initiative
title_fullStr Improving the Acceptance Rate of Centchroman As a Postpartum Contraceptive Through a Quality Improvement Initiative
title_full_unstemmed Improving the Acceptance Rate of Centchroman As a Postpartum Contraceptive Through a Quality Improvement Initiative
title_short Improving the Acceptance Rate of Centchroman As a Postpartum Contraceptive Through a Quality Improvement Initiative
title_sort improving the acceptance rate of centchroman as a postpartum contraceptive through a quality improvement initiative
topic Obstetrics/Gynecology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580608/
https://www.ncbi.nlm.nih.gov/pubmed/36277560
http://dx.doi.org/10.7759/cureus.29277
work_keys_str_mv AT sarkaravir improvingtheacceptancerateofcentchromanasapostpartumcontraceptivethroughaqualityimprovementinitiative
AT wadhawanisha improvingtheacceptancerateofcentchromanasapostpartumcontraceptivethroughaqualityimprovementinitiative
AT rajanjaly improvingtheacceptancerateofcentchromanasapostpartumcontraceptivethroughaqualityimprovementinitiative
AT nagabhushanaprerana improvingtheacceptancerateofcentchromanasapostpartumcontraceptivethroughaqualityimprovementinitiative
AT singhpreeti improvingtheacceptancerateofcentchromanasapostpartumcontraceptivethroughaqualityimprovementinitiative